Physician profile
Micah Ray Walker
NPI 1326451741
$768.17
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.02 · 2020: $36.36 · 2021: $52.68 · 2022: $92.82 · 2023: $214 · 2024: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $170.12 | 2023 | Rexulti |
| Abbott Laboratories | $164.14 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Revance Therapeutics, INC. | $156.86 | 2024 | Daxi, Daxxify |
| Lundbeck LLC | $58.66 | 2023-2024 | Rexulti |
| Avanir Pharmaceuticals, INC. | $45.22 | 2021-2022 | |
| Galderma Laboratories, L.P. | $31.64 | 2021-2024 | Dysport |
| Astellas Pharma US INC | $23.62 | 2020 | |
| Xeris Pharmaceuticals, INC. | $22.98 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.46 | 2022 | |
| Allergan, INC. | $17.36 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.02 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.77 | 2021 | |
| Sunovion Pharmaceuticals INC. | $12.74 | 2020 | |
| Abbvie INC. | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micah Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.